These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24850455)

  • 1. [Successful treatment of an essential thrombocythemia patient complicated by Sweet's syndrome with combination of chemotherapy and lenalidomide].
    Yamada M; Kuroda H; Yoshida M; Jomen W; Abe T; Sakurai T; Fujii S; Maeda M; Fujita M; Nagashima K; Matsuno T; Sato M; Kato J
    Rinsho Ketsueki; 2014 Apr; 55(4):440-4. PubMed ID: 24850455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azacitidine-associated Sweet's syndrome.
    Trickett HB; Cumpston A; Craig M
    Am J Health Syst Pharm; 2012 May; 69(10):869-71. PubMed ID: 22555082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptogenic organizing pneumonia in Sweet's syndrome: case report and review of the literature.
    Tzelepis E; Kampolis CF; Vlachadami I; Moschovi M; Alamani M; Kaltsas G
    Clin Respir J; 2016 Mar; 10(2):250-4. PubMed ID: 25196175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sweet's syndrome associated with hematological malignancies.
    Maller B; Bigness A; Moiño D; Greene J
    Leuk Res; 2020 Dec; 99():106461. PubMed ID: 33099235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome.
    Martinelli S; Rigolin GM; Leo G; Gafà R; Lista E; Cibien F; Sofritti O; Daghia G; Cavazzini F; Cuneo A
    Int J Hematol; 2014; 99(5):663-7. PubMed ID: 24554168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case of organizing pneumonia associated with sweet's syndrome].
    Nishimoto K; Suzuki S; Uto T; Sagisaka S; Sato J; Imokawa S; Yasuda K; Kageyama H; Suda T
    Arerugi; 2014 Jul; 63(7):938-44. PubMed ID: 25163580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case of Sweet's syndrome with extensive necrosis and ulcers accompanied by myelodysplastic syndrome.
    Kato T; Kawana S; Takezaki S; Kikuchi S; Futagami A
    J Nippon Med Sch; 2008 Jun; 75(3):162-5. PubMed ID: 18648174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sweet's syndrome after off-pump coronary artery bypass grafting].
    Rikitake K; Sato M; Ohtsubo S; Itoh T
    Kyobu Geka; 2009 Mar; 62(3):211-3. PubMed ID: 19280952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sweet's Syndrome and relapsing polychondritis signal myelodysplastic syndrome.
    Diamantino Fda E; Raimundo PM; Fidalgo AI
    An Bras Dermatol; 2011; 86(4 Suppl 1):S173-7. PubMed ID: 22068803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweet's syndrome and myelodysplasia: two entities with a common pathogenetic mechanism? A case report.
    Zappasodi P; Corso A; del Forno C
    Haematologica; 2000 Aug; 85(8):868-9. PubMed ID: 10942935
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sweet's syndrome in a patient with chronic myeloproliferative disorder during recombinant human granulocyte colony stimulating factor therapy].
    Shiga Y; Shichishima T; Kamei K; Watanabe K; Ishibashi T; Maruyama Y
    Rinsho Ketsueki; 1995 Apr; 36(4):353-8. PubMed ID: 7540225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sweet's syndrome induced by pegfilgrastim during a myelodysplastic syndrome AREB2: A case report].
    Nelis S; Azerad MA; Drowart A; Lewalle P; Efira A
    Rev Med Interne; 2019 Apr; 40(4):258-261. PubMed ID: 30551891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of relapsing neuro-Sweet's disease with corticosteroid and dapsone combination therapy.
    Fukae J; Noda K; Fujishima K; Wada R; Yoshiike T; Hattori N; Okuma Y
    Clin Neurol Neurosurg; 2007 Dec; 109(10):910-3. PubMed ID: 17889430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide in the treatment of recalcitrant Sweet's syndrome associated with myelodysplasia.
    Browning CE; Dixon JE; Malone JC; Callen JP
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S135-8. PubMed ID: 16021163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histiocytoid Sweet's Syndrome: A localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease.
    Magro CM; Momtahen S; Nguyen GH; Wang X
    Eur J Dermatol; 2015; 25(4):335-41. PubMed ID: 26067166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytic infiltrates as a presenting feature of Sweet's syndrome with myelodysplasia and response to cyclophosphamide.
    Evans AV; Sabroe RA; Liddell K; Russell-Jones R
    Br J Dermatol; 2002 Jun; 146(6):1087-90. PubMed ID: 12072085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case of recurrent Sweet's syndrome in a patient with relapsing polychondritis and myelodysplastic syndrome.
    Washio K; Oka M; Ohno K; Shimizu H; Kawano S; Kunisada M; Nishigori C
    J Dermatol; 2012 Aug; 39(8):731-3. PubMed ID: 22077478
    [No Abstract]   [Full Text] [Related]  

  • 18. [Appearance of Sweet's syndrome in a patient with myelodysplastic syndrome (MDS) without relation to the hematological findings of MDS].
    Hasegawa Y; Tomiyama J; Ninomiya H; Abe T
    Rinsho Ketsueki; 1989 Jun; 30(6):863-7. PubMed ID: 2795896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normolipemic xanthomatized Sweet's syndrome: A variant of Sweet's syndrome with myelodysplastic syndrome.
    Kamimura A; Yanagisawa H; Tsunemi Y; Kusano T; Arai E; Tsuchida T; Nakamura K
    J Dermatol; 2021 May; 48(5):695-698. PubMed ID: 33580905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythemia].
    Iizuka H; Yoshimi A; Yamamoto G; Masuda A; Nannya Y; Ichikawa M; Yatomi Y; Kurokawa M
    Rinsho Ketsueki; 2013 May; 54(5):468-72. PubMed ID: 23727686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.